We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10.11%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$47.1B
AUM Growth
+$2.61B
Cap. Flow
-$501M
Cap. Flow %
-1.06%
Top 10 Hldgs %
14.43%
Holding
3,576
New
705
Increased
706
Reduced
825
Closed
988

Top Buys

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$417M
2
META icon
Meta Platforms (Facebook)
META
+$383M
3
AMZN icon
Amazon
AMZN
+$308M
4
MSFT icon
Microsoft
MSFT
+$293M
5
GE icon
GE Aerospace
GE
+$263M

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$312M
2
BAC icon
Bank of America
BAC
+$292M
3
XOM icon
ExxonMobil
XOM
+$274M
4
LULU icon
lululemon athletica
LULU
+$238M
5
QCOM icon
Qualcomm
QCOM
+$228M

Sector Composition

Rank Sector Weight
1 Healthcare 17.05%
2 Technology 14.35%
3 Consumer Discretionary 13.97%
4 Financials 9.9%
5 Industrials 6.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IMCR icon
1701
Immunocore
IMCR
$1.68B
$1.19M ﹤0.01%
24,120
-6,260
-21% -$352K
IFS icon
1702
Intercorp Financial Services
IFS
$6.33B
$1.19M ﹤0.01%
52,134
+4,160
+9% +$97.9K
AJRD
1703
DELISTED
Aerojet Rocketdyne Holdings
AJRD
$1.18M ﹤0.01%
+21,028
New +$1.18M
RBOT.WS
1704
CALL
DELISTED
Vicarious Surgical Inc Warrants
RBOT.WS
$1.18M ﹤0.01%
520,000
EXTR icon
1705
Extreme Networks
EXTR
$3.8B
$1.18M ﹤0.01%
61,609
+41,956
+213% +$774K
GRTS
1706
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$1.17M ﹤0.01%
422,045
+175,719
+71% +$502K
MET icon
1707
MetLife
MET
$62.3B
$1.17M ﹤0.01%
20,206
+15,534
+332% +$1.05M
VISN
1708
Vistance Networks Inc
VISN
$2.61B
$1.17M ﹤0.01%
183,188
-339,843
-65% -$2.57M
VECO icon
1709
Veeco
VECO
$2.65B
$1.17M ﹤0.01%
55,180
+28,419
+106% +$585K
IMAQW
1710
CALL
DELISTED
International Media Acquisition Corp. Warrants
IMAQW
$1.16M ﹤0.01%
110,000
REYN icon
1711
Reynolds Consumer Products
REYN
$5.47B
$1.15M ﹤0.01%
41,801
-283,152
-87% -$8M
ZIMV
1712
DELISTED
ZimVie
ZIMV
$1.14M ﹤0.01%
158,058
+97,840
+162% +$834K
WCLD
1713
WisdomTree Cloud Computing Fund
WCLD
$270M
$1.14M ﹤0.01%
38,469
+13,530
+54% +$379K
PAYO icon
1714
Payoneer
PAYO
$2.42B
$1.14M ﹤0.01%
+181,805
New +$1.08M
CNSL
1715
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
$1.14M ﹤0.01%
441,583
+247,357
+127% +$887K
PKE icon
1716
Park Aerospace
PKE
$710M
$1.14M ﹤0.01%
+84,692
New +$1.19M
PL icon
1717
Planet Labs
PL
$7.06B
$1.14M ﹤0.01%
289,233
+176,073
+156% +$789K
CTOS.WS
1718
CALL
DELISTED
Custom Truck One Source, Inc. Warrants, exerciseable for Common Stock
CTOS.WS
$1.13M ﹤0.01%
166,665
EWD icon
1719
iShares MSCI Sweden ETF
EWD
$531M
$1.13M ﹤0.01%
31,820
+24,820
+355% +$866K
HDGE icon
1720
AdvisorShares Ranger Equity Bear ETF
HDGE
$58.1M
$1.13M ﹤0.01%
+44,444
New +$1.12M
AIZ icon
1721
Assurant
AIZ
$14B
$1.13M ﹤0.01%
9,403
-429
-4% -$53.7K
ALTIW
1722
CALL
DELISTED
AlTi Global Inc Warrant
ALTIW
$1.13M ﹤0.01%
90,000
-211,601
-70% -$155K
IXJ icon
1723
iShares Global Healthcare ETF
IXJ
$4.19B
$1.13M ﹤0.01%
13,500
+6,340
+89% +$525K
FXE icon
1724
Invesco CurrencyShares Euro Currency Trust
FXE
$341M
$1.12M ﹤0.01%
11,200
-30,100
-73% -$2.98M
HPQ icon
1725
CALL
HP
HPQ
$25.8B
$1.12M ﹤0.01%
38,200
-90,800
-70% -$2.61M

Similar funds

Marshall Wace's Q1 2023 Portfolio in Review

As of Q1 2023, Marshall Wace held 3,576 positions worth $47.1B, up 5.9% from $44.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Marshall Wace's Q1 2023 filing shows 705 new, 706 increased, 825 reduced and 988 closed positions. Its largest new stake was Madrigal Pharmaceuticals: 541,764 shares worth $131M. The largest sale was Cigna, an estimated $312M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Marshall Wace's largest Q1 2023 buy was Madrigal Pharmaceuticals: 541,764 shares worth $131M.
  • Marshall Wace added most to Walmart Inc in Q1 2023, an estimated $417M increase.
  • Marshall Wace's biggest Q1 2023 reduction was Cigna, cutting an estimated $312M.
  • Marshall Wace fully exited Merck in Q1 2023, selling an estimated $115M.
  • Marshall Wace's ten largest holdings make up 14% of its $47.1B portfolio in Q1 2023.
  • Marshall Wace opened 705 new positions and closed 988 in Q1 2023.
  • Marshall Wace's portfolio value rose 5.9% quarter-over-quarter to $47.1B.

Based on Marshall Wace's 13F filing for Q1 2023, filed 15 May 2023.